Bristol-Myers Squibb Company (BMY)

BMY (NYSE:Drugs)
pos +0.89
Today's Range: 48.41 - 49.21 | BMY Avg Daily Volume: 9,327,600
Last Update: 04/16/14 - 3:46 PM EDT
Volume: 6,600,478
YTD Performance: -9.37%
Open: $48.42
Previous Close: $48.17
52 Week Range: $39.18 - $57.49
Oustanding Shares: 1,650,232,566
Market Cap: 79,468,400,764
6-Month Chart
TheStreet Ratings Grade for BMY
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 9 9 9
Moderate Buy 1 1 1 1
Hold 4 5 6 6
Moderate Sell 0 0 0 0
Strong Sell 2 2 1 1
Mean Rec. 2.03 2.09 1.97 1.97
Latest Dividend: 0.36
Latest Dividend Yield: 2.63%
Dividend Ex-Date: 04/02/14
Price Earnings Ratio: 35.54
Price Earnings Comparisons:
BMY Sector Avg. S&P 500
35.54 31.10 28.47
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
-11.61% 18.21% 72.78%
Revenue -7.00 -0.16 -0.06
Net Income 3.20 -0.43 -0.17
EPS 32.90 -0.13 -0.05
Earnings for BMY:
Revenue 16.39B
Average Earnings Estimates
Qtr (03/14) Qtr (06/14) FY (12/14) FY (12/15)
Average Estimate $0.45 $0.43 $1.76 $1.71
Number of Analysts 10 8 13 11
High Estimate $0.58 $0.46 $1.82 $2.01
Low Estimate $0.40 $0.41 $1.70 $1.37
Prior Year $0.41 $0.44 $1.82 $1.76
Growth Rate (Year over Year) 9.76% -1.42% -3.09% -2.85%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
If they're renters, they can hurt you, and if they're owners, they can help.
There are stocks that benefit from whatever's causing the decline.
Even the bulls are keeping one foot out the door.
These sectors almost never see the kind of rallies they just had.
Mar 04, 2014 | 7:13 AM EST
Credit Suisse Healthcare Conference - 03/04/14 - 03/05/14 
A 5-day look at how situations like Ukraine have played out.
Monday's session was one any bull has to fear.
Feb 10, 2014 | 7:59 AM EST
BMY was upgraded from Market Perform to Outperform, BMO Capital said. $60 price target. Immuno-oncology pipeline should drive growth in...
Management expects another record EPS year in 2014.

Columnist Conversations

With the averages now flying upwards, with everyone scrambling to buy, it is startling to remember how palpabl...
Inability of Bank of America (BAC) to claw its way above 16.30-.40 resistance will increase the likelihood tha...
The Fed works for the government. The Federal government owes over $16 trillion. The Fed will likley never rai...
The key to analyzing the Treasury market is to look for the opposite of what makes logical/fundamental sense. ...


Columnist Tweets


Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.